Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CRNX will rise by +0.37% over the next 2 Weeks and hit $85.26 by Monday, September 14, 2026. In that time frame, CRNX's share price is expected to range between $80.64 and $89.72.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 14, 2026 | 80.64 | 85.26 | 89.72 |
| Sep 11, 2026 | 81.27 | 85.17 | 89.09 |
| Sep 10, 2026 | 81.94 | 85.14 | 88.41 |
| Sep 9, 2026 | 82.50 | 85.17 | 87.74 |
| Sep 8, 2026 | 83.04 | 85.17 | 87.32 |
| Sep 7, 2026 | 83.44 | 85.10 | 86.73 |
| Sep 4, 2026 | 83.82 | 85.01 | 86.16 |
| Sep 3, 2026 | 84.23 | 84.98 | 85.69 |
| Sep 2, 2026 | 84.62 | 85.01 | 85.36 |
| Sep 1, 2026 | 84.90 | 85.01 | 85.12 |
CRNX shares rose +0.13% in Monday, August 31, 2026's trading session, rising from a previous close of $84.84 to move at $84.95. The stock demonstrated notable intraday movement (see CRNX's key stats for a full breakdown), fluctuating between $84.92 and $85.03, a +0.12% trading range. While recent weeks have seen some volatility, CRNX has managed to secure a +0.27% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 7.6M shares changing hands, 6.88M more than the previous session. This amounted to $645.26M in total market activity.
Will CRNX Continue Its Upward Trend?
According to analyst ratings and projections for CRNX, Crinetics Pharmaceuticals, Inc. shares are anticipated to increase by +5.32%, potentially reaching $89.72 per share by September 14, 2026. Short-term technical indicators currently suggest a neutral sentiment for CRNX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 18 positive trading days within the past 30 sessions. Based on the CRNX stock forecast, now is a good time to buy CRNX stock because its current trading price is -0.36% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CRNX covering social and institutional perspectives.
CRNX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CRNX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 87.56% to 89.79%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 75.79%, indicates significant medium-term strength. However, the 100-day RSI, at 66.53%, points to growing bullish momentum over the long term. Insights into CRNX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Crinetics Pharmaceuticals Short-Term Forecasts
CRNX Forecast For Next 5 Days
Our algorithm anticipates Crinetics Pharmaceuticals (CRNX) stock could hit $111.50 by Sep 07, 2026. This represents a +31.26% rise from today's price, following a +0.61% change over the past five days.
CRNX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Crinetics Pharmaceuticals, Inc. (CRNX) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $95.54, which would mean a +12.47% increase from the current price of $84.95. Projections for this period range from a high of $121.13 to a low of $64.48.
CRNX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Crinetics Pharmaceuticals's price over the next three months point to a drop. CRNX stock is expected to peak at $99.33 on Nov 11, 2026 after potentially dipping to $76.29 on Oct 16, 2026. On average, CRNX is likely to trade around $82.86 in the coming 90 days.
Crinetics Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Crinetics Pharmaceuticals (CRNX) is expected to trade between $76.29 and $99.33 throughout 2026. This would result in an average price of $84.42, potentially offering investors a -0.62% return from current levels.
Crinetics Pharmaceuticals, Inc. Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, Crinetics Pharmaceuticals, Inc. (CRNX) is positioned to show a strong performance in September 2026. The price is predicted to move between $76.68 and $88.64, settling at an average of $82.69. This could translate to a -2.66% loss.
October 2026
Based on current market signals, Crinetics Pharmaceuticals, Inc. is projected to trend october 2026. We forecast a trading range from $76.29 to $87.87, with a likely average price of $82.05. Investors could expect a potential return of -3.41%.
November 2026
Our predictive algorithms indicate Crinetics Pharmaceuticals, Inc. stock may see a shift in November 2026. The expected range spans $77.45–$99.33, with an average target of $83.82. This represents a cautious outlook and a possible loss of -1.33%.
December 2026
Analyzing established trends, Crinetics Pharmaceuticals, Inc. looks set to move in December 2026. Projections place the stock between $79.60 and $97.00, averaging around $88.90. This suggests a +4.65% gain from current levels.
January 2027
Market indicators suggest Crinetics Pharmaceuticals, Inc. could experience notable changes during January 2027. Prices could fluctuate within $81.11 to $96.20, with a midpoint forecast of $89.91. The stock might deliver a +5.84% gain.
February 2027
Forecasting for February 2027, models estimate that Crinetics Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $79.66 and $91.22, averaging $85.32. This signals a positive trajectory with potential returns around +0.44%.
March 2027
According to our latest forecast models, Crinetics Pharmaceuticals, Inc. (CRNX) is positioned to show a strong performance in March 2027. The price is predicted to move between $79.01 and $90.48, settling at an average of $84.75. This could translate to a -0.24% loss.
April 2027
Based on current market signals, Crinetics Pharmaceuticals, Inc. is projected to trend april 2027. We forecast a trading range from $79.44 to $91.67, with a likely average price of $86.07. Investors could expect a potential return of +1.32%.
May 2027
Our predictive algorithms indicate Crinetics Pharmaceuticals, Inc. stock may see a shift in May 2027. The expected range spans $83.72–$100.07, with an average target of $91.98. This represents a positive outlook and a possible gain of +8.28%.
June 2027
Analyzing established trends, Crinetics Pharmaceuticals, Inc. looks set to move in June 2027. Projections place the stock between $82.88 and $99.82, averaging around $92.37. This suggests a +8.73% gain from current levels.
July 2027
Market indicators suggest Crinetics Pharmaceuticals, Inc. could experience notable changes during July 2027. Prices could fluctuate within $81.99 to $93.74, with a midpoint forecast of $88.01. The stock might deliver a +3.60% gain.
August 2027
Forecasting for August 2027, models estimate that Crinetics Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $81.93 and $94.14, averaging $87.43. This signals a positive trajectory with potential returns around +2.92%.
CRNX's history of dividends and stock splits also plays a role in long-term investor confidence.

